Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy. - Wikidata - wikimedia - TriplyDB

Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy.

Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy.

http://www.wikidata.org/entity/Q33692552

about

Management of Membranous Nephropathy in Western Countries Nephrotic syndrome-induced thromboembolism in adults Primary Nephrotic Syndrome in Adults as a Risk Factor for Pulmonary Embolism: An Up-to-Date Review of the Literature American Society of Nephrology quiz and questionnaire 2014: glomerular diseases Pharmacological treatment of primary membranous nephropathy in 2016.Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome The emerging role of coagulation proteases in kidney disease.Membranous nephropathy: Pilot study of a novel regimen combining cyclosporine and Rituximab.Primary glomerular diseases in the elderly.Primary Membranous Nephropathy.A systematic review and checklist presenting the main challenges for health economic modeling in personalized medicine: towards implementing patient-level models.Recent Treatment Advances and New Trials in Adult Nephrotic Syndrome.Characteristics of patients diagnosed with renal vein thrombosis and glomerulopathy: a case series.

P2860

Q26740477-71F09999-41B0-4716-A51D-86F1E316F45E Q26745704-33F25C67-7114-4AAD-ACFE-7B57B34BB0BA Q27023818-FBAA8EF8-F0EA-4BBB-B8EE-70C04974FA38 Q35278674-D609077F-339A-4159-A244-4F3027FE2D5D Q36106413-FC48DEC4-8D9C-41B2-89C7-F0C1844AB8E7 Q36314964-F17AED40-5BB8-4104-B53A-B8663E928CC4 Q37066587-734C4B46-A3BA-41F3-98CA-3A9894673726 Q37475696-F6C13D29-5EE6-41AA-A0D8-D25ED8D6514E Q38463829-E47BF63B-A8AD-4CE4-B48E-514AE6C2045D Q38760741-F025CE44-1A0C-4916-9B44-D76A454784A1 Q39039319-BFE2CDCE-E885-44B3-820C-194B45FFF60A Q39335899-A3CDA083-678F-4164-96D8-5D54D4148618 Q46664054-4738CD03-6DB3-49D2-945C-9109BC75F92C

P2860

Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy.

http://www.wikidata.org/entity/Q33692552

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Personalized prophylactic anti ...... s with membranous nephropathy.

@ast

Personalized prophylactic anti ...... s with membranous nephropathy.

@en

type

label

Personalized prophylactic anti ...... s with membranous nephropathy.

@ast

Personalized prophylactic anti ...... s with membranous nephropathy.

@en

prefLabel

Personalized prophylactic anti ...... s with membranous nephropathy.

@ast

Personalized prophylactic anti ...... s with membranous nephropathy.

@en

P1433

Q33692552-86E9FFF7-7405-4B2B-A242-DAE6F7138486

P1476

Q33692552-095C3602-D0F8-4061-A737-F40EC67B930D

P2093

Q33692552-0FAFF9B7-03A4-4445-92D1-8BD75A439226

Q33692552-15234218-D38E-426F-9F44-55A875ACCF52

Q33692552-2061A2CA-7326-4BE9-AF9B-818E5D6F8398

Q33692552-26F3C183-AF33-4DB9-AE97-0E61E86D73F4

Q33692552-34E01A7C-64BD-410C-9EB9-CEFDCD657A43

Q33692552-5179BAFA-F52B-41E8-B316-ADEB68055595

Q33692552-59DDC18A-5211-47D7-8F10-6510C38D68D1

Q33692552-67F2DF27-42FE-4A89-9320-FB6B51229643

Q33692552-7D554B22-B2F9-4ECC-954A-0943F429D8CF

Q33692552-8A6F346C-28E4-4A3F-A4E0-234119F0F986

P2860

Q33692552-000F9DA1-375A-4A5C-9D51-6C52159A7D9E

Q33692552-0033B7A8-3FC1-47F5-A30B-F9925EF3B886

Q33692552-02011A89-2362-4C7B-9A4D-2856D66ACE75

Q33692552-0CCB09BA-9CE7-4728-9A4B-FE31EC419B1C

Q33692552-1B50DD95-C611-433F-93AB-60ECD63B5F8F

Q33692552-2587BE44-BDCC-4B76-8C94-2802EB9B0015

Q33692552-2B9AAD8E-137A-4D6A-8622-0C4C4BDF38E8

Q33692552-307F79B2-98B3-4C05-B635-306574CB0CC4

Q33692552-3C38189D-9284-46CD-9C01-E75274D8B4A3

Q33692552-4C657853-E01E-4C44-95A6-A4C5B256F23E

P2888

Q33692552-BD45CDA2-A706-4F9F-8C93-B2E0909882C6

P304

Q33692552-45A07A8A-3E60-4858-ABD3-B6E32CA4009A

P31

Q33692552-C5246D89-8920-4FDD-B847-DA5F9C6FF196

P356

Q33692552-1E98701B-CAF0-47C0-A86E-1A6094963C53

P407

Q33692552-0DBD61E1-90E7-4898-8C36-6CCF2763C755

P433

Q33692552-9DC6282F-0D0E-4182-8C38-C0BB4DB84B86

P478

Q33692552-8BF4D63B-D052-421C-A1CB-53EDC0243738

P50

Q33692552-5EEE934D-5EA5-4EC7-AD46-1C18D44BCDAC

Q33692552-CD14DDF2-2A12-43C2-9CCB-5F8696A6C14E

Q33692552-FB133D6B-CF14-4409-9DB7-FD848A916729

P577

Q33692552-BD6D450F-48F8-4640-854E-8FFE3AC5B4E7

P6179

Q33692552-93A370AE-6EBD-4F1B-9998-F29A7BECAB17

P698

Q33692552-2DA17E94-0FF7-46BF-815C-34425F16D531

P921

Q33692552-D822899F-7599-4CA7-A5AE-E9CE5227C173

P932

Q33692552-55F63C8B-D504-4389-BC34-21E69D0CAFEB

P356

P1433

Kidney International

P1476

Personalized prophylactic anti ...... ts with membranous nephropathy

@en

P2093

Caroline J Poulton

http://www.w3.org/2001/XMLSchema#string

Daniel C Cattran

http://www.w3.org/2001/XMLSchema#string

Heather N Reich

http://www.w3.org/2001/XMLSchema#string

J Charles Jennette

http://www.w3.org/2001/XMLSchema#string

Michelle A Hladunewich

http://www.w3.org/2001/XMLSchema#string

Patrick H Nachman

http://www.w3.org/2001/XMLSchema#string

Ronald J Falk

http://www.w3.org/2001/XMLSchema#string

Sameer Tannous

http://www.w3.org/2001/XMLSchema#string

Sean J Barbour

http://www.w3.org/2001/XMLSchema#string

Shannon L Mahoney

http://www.w3.org/2001/XMLSchema#string

P2860

A new equation to estimate glomerular filtration rate

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.

Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum.

Venous thromboembolism in patients with membranous nephropathy

Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management.

Renal vein thrombosis in nephrotic syndrome--a prospective study and review.

Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism.

Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.

P2888

P304

1412-1420

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/KI.2013.476

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

Vimal K. Derebail

Andrea K Biddle

P577

2013-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1051219878

http://www.w3.org/2001/XMLSchema#string

P698

24336031

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

4040154

http://www.w3.org/2001/XMLSchema#string